Be tough on people not disciplined: Bharat Biotech's Suchitra Ella
Ella was the company’s go-to person during the production of its indigenously developed Covid-19 vaccine, Covaxin—engaging with multiple ministries almost on a daily basis.
covaxin
November 2021
October 2021
May 2021
March 2021
February 2021
January 2021
Next target for Covid vaccine: 200 crore; How soon?
100 crore shots and rising.
Eager for WHO approval for Covaxin: Suchitra Ella
As countries open their borders to travel, tourism and education, Bharat Biotech’s Covaxin awaits WHO’s nod on October 26. Co-founder, Suchitra Ella, is hopeful of a positive answer.
Rare clots and heart issues by Covid vaccines call for larger trials in kids
Covaxin gets approval for 2-18 year olds; limited clinical trials may be inadequate to detect issues, say experts.
Scarcity-hit India looks for imported vaccines
At a time when the entire world is frantically trying to procure more vaccine doses, it is going to be a protracted struggle for India.
The Ellas of Bharat Biotech: The gift of the jab
Bharat Biotech, founded by Krishna Ella and his wife Suchitra, has been at the forefront of making vaccines for a while. Yet it took a global pandemic for the spotlight to shine on the company.
Covid-19 vaccine: How ready is India’s supply chain?
As India starts the second phase of its Covid-19 vaccine deployment, the question on the viability of its supply chain network, and its cold storage capability, has become more pertinent than ever.
How Godrej joined the global vaccination drive
Godrej & Boyce has built an array of made-in-India ultra-low temperature freezers for the world.
Covid-19 vaccines: India to face a problem of plenty
Prices of vaccines may crash in the next few months. The vaccine makers will have to strike while the iron is hot.
Bharat Biotech’s perception battle
For BBIL’s founder Krishna Ella, the roll-out of a made-in-India vaccine, Covaxin, is peppered with challenges. Two recent deals with Brazilian and American firms have now buoyed him.
